Healthcare Industry Reports

Reports > Healthcare > Selected Report

Pain Management Drugs Market by Manufacturers, Countries, Type and Application, Forecast 2017 to 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Pain is complex, so there are many treatment options medications, therapies, and mindbody techniques.

Scope of the Report:
This report focuses on the Pain Management Drugs in Global market, especially in North America, Europe and AsiaPacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
AsiaPacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Generic Opioids
Branded Opioids
NSAIDs
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Drugstores

There are 15 Chapters to deeply display the global Pain Management Drugs market.

Chapter 1, to describe Pain Management Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Pain Management Drugs, with sales, revenue, and price of Pain Management Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Pain Management Drugs, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Pain Management Drugs market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Pain Management Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Pain Management Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Generic Opioids
1.2.2 Branded Opioids
1.2.3 NSAIDs
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Drugstores
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (20122022)
1.4.1.2 Canada Market States and Outlook (20122022)
1.4.1.3 Mexico Market States and Outlook (20122022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (20122022)
1.4.2.2 France Market States and Outlook (20122022)
1.4.2.3 UK Market States and Outlook (20122022)
1.4.2.4 Russia Market States and Outlook (20122022)
1.4.2.5 Italy Market States and Outlook (20122022)
1.4.3 AsiaPacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (20122022)
1.4.3.2 Japan Market States and Outlook (20122022)
1.4.3.3 Korea Market States and Outlook (20122022)
1.4.3.4 India Market States and Outlook (20122022)
1.4.3.5 Southeast Asia Market States and Outlook (20122022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (20122022)
1.4.4.2 Egypt Market States and Outlook (20122022)
1.4.4.3 Saudi Arabia Market States and Outlook (20122022)
1.4.4.4 South Africa Market States and Outlook (20122022)
1.4.4.5 Nigeria Market States and Outlook (20122022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Pain Management Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Pain Management Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 GSK Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.3 Grunenthal
2.3.1 Business Overview
2.3.2 Pain Management Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Grunenthal Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Pain Management Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Bayer Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Pain Management Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Sanofi Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Pain Management Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Eli Lilly Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 Pain Management Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 AstraZeneca Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.8 Endo
2.8.1 Business Overview
2.8.2 Pain Management Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Endo Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.9 Merck
2.9.1 Business Overview
2.9.2 Pain Management Drugs Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Merck Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.10 Depomed
2.10.1 Business Overview
2.10.2 Pain Management Drugs Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Depomed Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.11 Yunnan Baiyao
2.11.1 Business Overview
2.11.2 Pain Management Drugs Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Yunnan Baiyao Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.12 Teva
2.12.1 Business Overview
2.12.2 Pain Management Drugs Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Teva Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.13 J&J
2.13.1 Business Overview
2.13.2 Pain Management Drugs Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 J&J Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.14 Allergan
2.14.1 Business Overview
2.14.2 Pain Management Drugs Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Allergan Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
2.15 Purdue
2.15.1 Business Overview
2.15.2 Pain Management Drugs Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Purdue Pain Management Drugs Sales, Price, Revenue, Gross Margin and Market Share (20162017)
3 Global Pain Management Drugs Market Competition, by Manufacturer
3.1 Global Pain Management Drugs Sales and Market Share by Manufacturer
3.2 Global Pain Management Drugs Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Pain Management Drugs Manufacturer Market Share
3.3.2 Top 6 Pain Management Drugs Manufacturer Market Share
3.4 Market Competition Trend
4 Global Pain Management Drugs Market Analysis by Regions
4.1 Global Pain Management Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Pain Management Drugs Sales by Regions (20122017)
4.1.2 Global Pain Management Drugs Revenue by Regions (20122017)
4.2 North America Pain Management Drugs Sales and Growth (20122017)
4.3 Europe Pain Management Drugs Sales and Growth (20122017)
4.4 AsiaPacific Pain Management Drugs Sales and Growth (20122017)
4.5 South America Pain Management Drugs Sales and Growth (20122017)
4.6 Middle East and Africa Pain Management Drugs Sales and Growth (20122017)
5 North America Pain Management Drugs by Countries
5.1 North America Pain Management Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Pain Management Drugs Sales by Countries (20122017)
5.1.2 North America Pain Management Drugs Revenue by Countries (20122017)
5.2 USA Pain Management Drugs Sales and Growth (20122017)
5.3 Canada Pain Management Drugs Sales and Growth (20122017)
5.4 Mexico Pain Management Drugs Sales and Growth (20122017)
6 Europe Pain Management Drugs by Countries
6.1 Europe Pain Management Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Pain Management Drugs Sales by Countries (20122017)
6.1.2 Europe Pain Management Drugs Revenue by Countries (20122017)
6.2 Germany Pain Management Drugs Sales and Growth (20122017)
6.3 UK Pain Management Drugs Sales and Growth (20122017)
6.4 France Pain Management Drugs Sales and Growth (20122017)
6.5 Russia Pain Management Drugs Sales and Growth (20122017)
6.6 Italy Pain Management Drugs Sales and Growth (20122017)
7 AsiaPacific Pain Management Drugs by Countries
7.1 AsiaPacific Pain Management Drugs Sales, Revenue and Market Share by Countries
7.1.1 AsiaPacific Pain Management Drugs Sales by Countries (20122017)
7.1.2 AsiaPacific Pain Management Drugs Revenue by Countries (20122017)
7.2 China Pain Management Drugs Sales and Growth (20122017)
7.3 Japan Pain Management Drugs Sales and Growth (20122017)
7.4 Korea Pain Management Drugs Sales and Growth (20122017)
7.5 India Pain Management Drugs Sales and Growth (20122017)
7.6 Southeast Asia Pain Management Drugs Sales and Growth (20122017)
8 South America Pain Management Drugs by Countries
8.1 South America Pain Management Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Pain Management Drugs Sales by Countries (20122017)
8.1.2 South America Pain Management Drugs Revenue by Countries (20122017)
8.2 Brazil Pain Management Drugs Sales and Growth (20122017)
8.3 Argentina Pain Management Drugs Sales and Growth (20122017)
8.4 Columbia Pain Management Drugs Sales and Growth (20122017)
9 Middle East and Africa Pain Management Drugs by Countries
9.1 Middle East and Africa Pain Management Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pain Management Drugs Sales by Countries (20122017)
9.1.2 Middle East and Africa Pain Management Drugs Revenue by Countries (20122017)
9.2 Saudi Arabia Pain Management Drugs Sales and Growth (20122017)
9.3 UAE Pain Management Drugs Sales and Growth (20122017)
9.4 Egypt Pain Management Drugs Sales and Growth (20122017)
9.5 Nigeria Pain Management Drugs Sales and Growth (20122017)
9.6 South Africa Pain Management Drugs Sales and Growth (20122017)
10 Global Pain Management Drugs Market Segment by Type
10.1 Global Pain Management Drugs Sales, Revenue and Market Share by Type (20122017)
10.1.1 Global Pain Management Drugs Sales and Market Share by Type (20122017)
10.1.2 Global Pain Management Drugs Revenue and Market Share by Type (20122017)
10.2 Generic Opioids Sales Growth and Price
10.2.1 Global Generic Opioids Sales Growth (20122017)
10.2.2 Global Generic Opioids Price (20122017)
10.3 Branded Opioids Sales Growth and Price
10.3.1 Global Branded Opioids Sales Growth (20122017)
10.3.2 Global Branded Opioids Price (20122017)
10.4 NSAIDs Sales Growth and Price
10.4.1 Global NSAIDs Sales Growth (20122017)
10.4.2 Global NSAIDs Price (20122017)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (20122017)
10.5.2 Global Others Price (20122017)
11 Global Pain Management Drugs Market Segment by Application
11.1 Global Pain Management Drugs Sales Market Share by Application (20122017)
11.2 Hospitals Sales Growth (20122017)
11.3 Clinics Sales Growth (20122017)
11.4 Drugstores Sales Growth (20122017)
12 Pain Management Drugs Market Forecast (20172022)
12.1 Global Pain Management Drugs Sales, Revenue and Growth Rate (20172022)
12.2 Pain Management Drugs Market Forecast by Regions (20172022)
12.2.1 North America Pain Management Drugs Market Forecast (20172022)
12.2.2 Europe Pain Management Drugs Market Forecast (20172022)
12.2.3 AsiaPacific Pain Management Drugs Market Forecast (20172022)
12.2.4 South America Pain Management Drugs Market Forecast (20172022)
12.2.5 Middle East and Africa Pain Management Drugs Market Forecast (20172022)
12.3 Pain Management Drugs Market Forecast by Type (20172022)
12.4 Pain Management Drugs Market Forecast by Application (20172022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 26027

Category: 11

Published date: 2017-09-11 18:14:51

Number of Pages: 120

Publisher Name: GIR

Over all Rating: 94 % (Average of Ratings provided by clients)